Adrienne H Brouwers Selected Research

Adrienne H Brouwers Research Topics

Disease

47	Neoplasms (Cancer) 01/2024 - 08/2003
12	Thyroid Neoplasms (Thyroid Cancer) 12/2022 - 12/2012
10	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 08/2003
9	Breast Neoplasms (Breast Cancer) 02/2024 - 02/2012
7	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2021 - 09/2008
4	Disease Progression 10/2022 - 09/2005
4	Melanoma (Melanoma, Malignant) 01/2021 - 10/2009
4	Carcinoid Tumor (Carcinoid) 10/2011 - 07/2005
3	Primary Hyperparathyroidism 11/2023 - 11/2017
3	Neoplasm Metastasis (Metastasis) 06/2022 - 07/2011
2	Adenoma (Adenomas) 11/2023 - 03/2011
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 11/2023 - 07/2019
2	Squamous Cell Carcinoma of Head and Neck 10/2022 - 01/2010
2	Sarcoma (Soft Tissue Sarcoma) 06/2018 - 06/2018
2	Atrial Fibrillation 12/2017 - 12/2015
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2016 - 05/2012
2	Insulinoma 01/2015 - 01/2011
2	Islet Cell Adenoma (Islet Cell Tumors) 05/2012 - 03/2008
2	Pheochromocytoma 01/2010 - 03/2009
1	Starvation 12/2023
1	Adrenal incidentaloma 01/2023
1	Parathyroid Diseases (Parathyroid Disorders) 11/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2022
1	Bone Resorption 11/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Adenocarcinoma 01/2019
1	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 01/2019

Drug/Important Bio-Agent (IBA)

12	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2024 - 10/2009
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
7	89Zr-bevacizumabIBA 01/2017 - 08/2007
6	Dihydroxyphenylalanine (Dopa)IBA 06/2022 - 09/2009
6	CatecholaminesIBA 08/2019 - 07/2005
6	Monoclonal AntibodiesIBA 08/2019 - 02/2004
6	Proteins (Proteins, Gene)FDA Link 01/2015 - 02/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 08/2007
5	Thyroglobulin FDA Link 12/2022 - 08/2013
5	fluorodopa F 18IBA 03/2021 - 03/2008
4	G250 monoclonal antibodyIBA 01/2023 - 09/2003
4	Tumor Biomarkers (Tumor Markers)IBA 12/2022 - 01/2011
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2009
4	Bevacizumab (Avastin)FDA Link 01/2015 - 08/2007
3	ErbB Receptors (EGF Receptor)IBA 01/2024 - 07/2010
3	zirconium-89-trastuzumabIBA 01/2024 - 02/2012
3	Radioisotopes (Radionuclides)IBA 06/2022 - 09/2003
3	Trastuzumab (Herceptin)FDA Link 01/2022 - 07/2010
3	IodineIBA 01/2022 - 08/2013
3	AntibodiesIBA 01/2017 - 09/2005
3	Everolimus FDA Link 01/2017 - 01/2011
2	Immune Checkpoint InhibitorsIBA 12/2022 - 12/2018
2	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2022 - 03/2008
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 06/2022 - 03/2021
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2021 - 05/2016
2	EnzymesIBA 09/2021 - 07/2013
2	Sunitinib (Sutent)FDA Link 01/2015 - 01/2011
2	InterferonsIBA 01/2015 - 08/2003
2	Serotonin (5 Hydroxytryptamine)IBA 10/2011 - 03/2008
2	Phenylalanine (L-Phenylalanine)FDA Link 09/2008 - 03/2008
2	AntigensIBA 09/2003 - 08/2003
1	Ado-Trastuzumab EmtansineIBA 01/2024
1	Methionine (L-Methionine)FDA Link 11/2023
1	Choline (Choline Chloride)IBA 11/2023
1	AutoantibodiesIBA 12/2022
1	CalciumIBA 11/2022
1	Parathyroid Hormone (Parathormone)IBA 11/2022
1	durvalumabIBA 10/2022
1	B7-H1 AntigenIBA 10/2022
1	Peptide Receptors (Peptide Receptor)IBA 06/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2022
1	OsteocalcinIBA 11/2021
1	Collagen Type I (Type I Collagen)IBA 11/2021
1	collagen type I trimeric cross-linked peptideIBA 11/2021
1	Peptide Hydrolases (Proteases)FDA Link 10/2021
1	Peptides (Polypeptides)IBA 10/2021
1	Alanine (L-Alanine)FDA Link 09/2021
1	Carboxy-LyasesIBA 09/2021
1	Dopamine (Intropin)FDA LinkGeneric 09/2021
1	Amino Acids FDA Link 09/2021
1	Ga(III)-DOTATOCIBA 03/2021
1	FluorineIBA 01/2021
1	AminesIBA 08/2019
1	MCOIBA 01/2019
1	Carcinoembryonic AntigenIBA 01/2019
1	atezolizumabIBA 12/2018
1	Programmed Cell Death 1 ReceptorIBA 12/2018
1	LigandsIBA 12/2018
1	Levodopa (L Dopa)FDA LinkGeneric 08/2018
1	lumretuzumabIBA 10/2017
1	pro-brain natriuretic peptide (1-76)IBA 08/2017
1	Indicators and Reagents (Reagents)IBA 01/2017

Therapy/Procedure

13	Therapeutics 12/2022 - 01/2008
5	Immunotherapy 12/2022 - 08/2003
3	Radioimmunotherapy 10/2005 - 02/2004
2	Thyroidectomy 12/2015 - 01/2015
1	Drug Tapering 12/2023
1	PET protocol 07/2019
1	Liver Transplantation 01/2019
1	Roux-en-Y Anastomosis (Anastomosis, Roux en Y) 01/2019
1	Radiotherapy 06/2018
1	Parathyroidectomy 11/2017